Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations

Neurology

Volumn 47, Issue 6, 1996, Pages 1546-1551

  Przedborski, S ^a,d   Dhawan, V ^b   Donaldson, D M ^a   Murphy, P L ^a   McKenna Yasek, D ^c   Mandel, F S ^b   Brown Jr , R H ^c   Eidelberg, D ^b  

^a Columbia University ^*  (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FLUORODOPA F 18; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR NEURON DISEASE; NIGRONEOSTRIATAL SYSTEM; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0029753029     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.6.1546     Document Type: Article

References (41)

1. Rowland LP. Hereditary and acquired motor neuron diseases. In: Rowland LP, ed. Merritt's textbook of neurology. 9th ed. Philadelphia: Williams and Wilkins, 1995:742-749.
2. Rowland LP. Amyotrophic lateral sclerosis: human challenge for neuroscience. Proc Natl Acad Sci USA 1995;92:1251-1253.
3. Alexianu ME, Mohamed AH, Smith RG, Colom LV, Appel SH. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J Neurochem 1994;63:2365-2368.
4. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62.
5. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 1993;261:1047-1051.
6. Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994;91:8292-8296.
7. Rothstein JD, Bristol LA, Hosler B, Brown RH Jr., Kuncl RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 1994;91: 4155-4159.
8. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994;264:1772-1775.
9. Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995;14:1105-1116.
10. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1995;92:689-693.
11. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW. Superoxide dismutase is an abundant component in cell bodies dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 1995;92:954-958.
12. Kato S, Oda M, Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 1993;19:300-304.
13. Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 1993;342:1016-1018.
14. Fahn S. Parkinsonism. In: Wyngaarden JB, Smith LH Jr., eds. Cecil's textbook of medicine. 18th ed. Philadelphia: Saunders, 1988:2143-2147.
15. Bandmann O, Davis MB, Marsden CD, Harding AE. Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1995;59:90-91.
16. Przedborski S, Kostic V, Jackson-Lewis V, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 1992;12:1658-1667.
17. Troy CM, Shelanski ML. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci USA 1994;91:6384-6387.
18. Greenlund LJS, Deckwerth TL, Johnson EM, Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 1995;14: 303-315.
19. Eidelberg D. Positron emission tomography studies in parkinsonism. Neurol Clin 1992;10:421-433.
20. Brooks DJ. Functional imaging of movement disorders. In: Marsden CD, Fahn S, eds. Movement disorders 3. Boston: Butterworth-Heinemann, 1994:65-87.
21. Takikawa S, Dhawan V, Chaly T, et al. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. J Nucl Med 1994;35: 955-963.
22. Younger DS, Rowland LP, Latov N, et al. Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes. Neurology 1990;40:595-599.
23. Przedborski S, Donaldson D, Murphy PL, et al. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration 1996;5:57-64.
24. Robeson W, Dhawan V, Takikawa S. Superpett 3000 time-of-flight PET tomograph: optimization of factors affecting quantitation. IEEE Trans Nucl Sci 1993;40:135-142.
25. Spetsieris P, Dhawan V, Margouleff D, Eidelberg D. A versatile graphic-image processing package for imaging cerebral function. IEEE Comput Graph 1993;13:15-26.
26. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme, 1988.
27. Ishikawa T, Dhawan V, Chaly T, et al. Clinical significance of striatal dopa decarboxylase activity in Parkinson's disease. J Nucl Med 1996;37:216-222.
28. Wolf HK, Crain BJ, Siddique T. Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis. Clin Neuropathol 1991;6:291-296.
29. Biemond A, Beck W. Neural muscle atrophy with degeneration of the substantia nigra. Confina Neurol 1955;15:142-153.
30. Castaingne P, Lhermitte F, Cambier J, Escourolle R, Le Bigot P. Etude neuropathologique de 61 observations de sclérose lateral amyotrophique. Discussion nosologique. Rev Neurol 1972;127:401-414.
31. Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusion in the anterior horn cells. Arch Neurol 1967;16:232-243.
32. Tanaka J, Nakamura H, Tabuchi Y, Takahashi K. Familial amyotrophic lateral sclerosis: features of multisystem degeneration. Acta Neuropathol (Berl) 1984;64:22-29.
33. Chen K-M, Chase TN. Parkinsonism-dementia. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology. Extrapyramidal disorders. Amsterdam: Elsevier, 1986:167-183.
34. Adams RD, Salam-Adams M. Striatonigral degeneration. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of clinical neurology. Extrapyramidal disorders. Amsterdam: Elsevier, 1986:205-212.
35. Mizutani T, Sakamaki S, Tsuchiya N, et al. Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol (Berl) 1992;84:372-377.
36. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-694.
37. Smith RG, Appel SH. Molecular approaches to amyotrophic lateral sclerosis. Annu Rev Med 1995;46:133-145.
38. Dawson VL. Nitric oxide: role in neurotoxicity. Clin Exp Pharmacol Physiol 1995;22:305-308.
39. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994;44:1872-1877.
40. Rabizadeh S, Gralla EB, Borchelt DR, et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA 1995;92:3024-3028.
41. Przedborski S, Giladi N, Takikawa S, et al. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome. Neurology 1994;44:1622-1628.